Acquiring Company
Abiogen Pharma S.p.A
Acquired Company
EffRx Pharmaceuticals SA
Description
Abiogen Pharma S.p.A., Italian leading company in the field of osteoarticular and bone metabolism diseases, is pleased to announce the acquisition of a 97,09% stake in EffRx Pharmaceuticals SA, a Swiss company that develops and markets prescription drugs targeted in particular to musculoskeletal and rare pathologies on European and international markets. The key active agent developed by EffRx is buffered soluble alendronate which belongs to a class of non-hormonal pharmaceuticals known as bisphosphonates. This medication has been distributed in Italy by Abiogen Pharma since 2014 under a licence agreement.
Quick answer
Abiogen Pharma S.p.A is acquiring EffRx Pharmaceuticals SA, announced May 29, 2023.
- How much did Abiogen Pharma S.p.A pay for EffRx Pharmaceuticals SA?
- The deal value was not disclosed.
- What does Abiogen Pharma S.p.A do?
- -- Abiogen Pharma is headquartered in Pisa, Italy.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lilly To Acquire Sigilon Therapeutics (June 29, 2023)
- Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology (June 20, 2023)
- Solmetex, Llc Acquires Impladent Ltd. (June 5, 2023)
- Serb Pharmaceuticals Acquires Vistogard® And Xuriden® From Wellstat Therapeutics (July 13, 2023)
- Biocoat Acquires Chempilots To Expand Its Biomaterial Platform (July 11, 2023)
- Astellas Completes Acquisition Of Iveric Bio (July 11, 2023)
Who to call at Abiogen Pharma S.p.A, and when
When Abiogen Pharma S.p.A changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Abiogen Pharma S.p.A raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Abiogen Pharma S.p.A, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Abiogen Pharma S.p.A. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Abiogen Pharma S.p.A makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired EffRx Pharmaceuticals SA?
EffRx Pharmaceuticals SA was acquired by Abiogen Pharma S.p.A. The deal was reported on May 29, 2023. -- Abiogen Pharma is headquartered in Pisa, Italy. Abiogen Pharma S.p.A is privately held and operates in Manufacturing.
When did Abiogen Pharma S.p.A acquire EffRx Pharmaceuticals SA?
Abiogen Pharma S.p.A's acquisition of EffRx Pharmaceuticals SA was reported on May 29, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does EffRx Pharmaceuticals SA do?
-- EffRx was established in 2010 and is headquartered in Freienbach, Switzerland. The company develops and commercializes drugs, targeted in particular to musculoskeletal and rare diseases. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.